Navigation Links
Pharmaxis Closes Share Purchase Plan
Date:11/18/2007

SYDNEY, Australia, Nov. 18 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS, Nasdaq: PXSL) today announced it had raised $11.7 million from its Share Purchase Plan which closed on 9 November 2007. Shareholders of the company were given the opportunity to purchase up to $5,000 worth of shares each at the $3.90 price paid by institutional investors in the recent placement.

A total of 2,496 shareholders participated in the plan under which the company will issue approximately 3 million new shares and receive cash of approximately $11.7 million.

Dr Alan Robertson, Chief Executive Officer of Pharmaxis said, "We are very encouraged with the level of support from our shareholders. Approximately half participated in the plan, and the average investment was over $4,600."

Shares will be issued today, 16th November 2007, and are expected to be listed on the Australian Securities Exchange on 19 November 2007. Holding statements will be posted on or about 19 November 2007.

About Pharmaxis

Pharmaxis (ACN 082 811 630) is a pharmaceutical company involved in the research, development and commercialization of therapeutic products for chronic respiratory and immune disorders. Its development pipeline of products include, Aridol for the management of asthma, Bronchitol for cystic fibrosis, bronchiectasis and chronic obstructive pulmonary disease (COPD) and PXS64 for the treatment of multiple sclerosis.

Founded in 1998, Pharmaxis is listed on the Australian Stock Exchange (symbol PXS), and on NASDAQ Global Market (symbol PXSL). The company is headquartered in Sydney at its TGA-approved manufacturing facilities. For more information about Pharmaxis, go to http://www.pharmaxis.com.au or contact Jane Sugden, Investor Relations +61 2 9454 7230.

Forward-Looking Statements

The statements contained in this media release that are not purely historical are forward-looking statement
'/>"/>

SOURCE Pharmaxis Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Phase III Trial Finds Pharmaxis Bronchitol Effective
2. Pharmaxis Announces Placement of $50 Million and Share Purchase Plan
3. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
4. Genmab Discloses Target and Development Plans for HuMax-Inflam
5. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
6. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
7. Gilde Healthcare Partners Closes EUR 150 Million European Healthcare Venture Fund
8. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
9. BioVex Closes Second Round of Series E Financing
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...wswire/ -- The Eniva Research Group has,released r...Linus Pauling,Micronutrient Research Institute at ...va Health Supplement VIBE(R) possessed DNA protect...third party testing was,performed as part of an on...hanisms by which the Eniva VIBE nutraceutical impa...
(Date:7/3/2008)...wire/ - OncoGenex Technologies Inc. and Isis,Pharm...that the companies,have amended their agreement an...ts lead cancer drug OGX-011. Under the amended agr...ture development activities,costs and partnering ...be,responsible for funding 35% of development cost...
(Date:7/3/2008)...RNewswire-FirstCall/ -- AMDL, Inc. (Amex:,ADL), a ...tered in Tustin,Ca., with operations in Shenzhen,... released its investor presentation which is avail...://www.amdl.com ., About AMDL:, AMDL, Inc. is a ...ny is,headquartered in Tustin, California with ope...
(Date:7/2/2008)...ing Stent to Demonstrate Superiority Over,Market-L...United States for Treatment of Co.../- Abbott today,announced t...proved the,XIENCE(TM) V Everolimus Eluting Coronar...y disease. XIENCE V is the only drug eluting stent...
Breaking Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2OncoGenex increases economic interest in lead cancer drug OGX-011 2OncoGenex increases economic interest in lead cancer drug OGX-011 3OncoGenex increases economic interest in lead cancer drug OGX-011 4AMDL Announces Investor Relations Presentation Available on Website 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 3FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 4FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 5
...gene Corp. will appeal the jury verdict that Madis...alifornia company last week. , ,Stratagene on Satu...n rendered last Wednesday in the United States Dis... The jury awarded Third Wave $5.29 million in da...t "believes that the jury,s verdict and the damage...
...ference comes together , there,s always one or two...own right, but for one reason or another, they jus...aunch at DEMO. , ,One such company is Nutrihand ,...ex-Microsofter Soraya Bittencort, Mountain View, C...ased service that helps diabetics and their health...
...stics has selected RedPrairie Corp.,s DLx Labor ... productivity and customer service throughout its ...sday. DCS Logistics , with corporate offices in D...e solution at all of its logistics centers. , ,DS...panies such as Kellogg,s, Unilever, Yamaha, Georgi...
...entative measures, Katrina caught many businesses ...ofessor James Carlini, what disaster recovery plan...d your home and how updated are they? , ,While mo...and residential aspects, few reports have really t...inesses down in the South. , ,They already have sa...
Other Biology Technology:Stratagene to appeal verdict won by Third Wave 2The one that got away 2The one that got away 3Hurricane Katrina: Many disaster recovery systems were outdated 2Hurricane Katrina: Many disaster recovery systems were outdated 3Hurricane Katrina: Many disaster recovery systems were outdated 4
(Date:7/2/2008)...specter of a worldwide outbreak of avian or "bird ...drugs are desperately needed since some strains of...e current roster of anti-flu remedies. , Now, a ... resources at the San Diego Supercomputer Center (...han two dozen promising and novel compounds from w...
(Date:7/2/2008)... at North Carolina State University have found tha... if there is an abrasion, providing insight into p... or individuals involved in the manufacturing of q...cal applications of the tiny nanoparticles. , W...t sizes, shapes and surface coatings do not penetr...
(Date:7/2/2008)...se is available in German . , Metabolomics aims...of a cell or a tissue. The exponents of bioinforma... pre-clinical metabolomics study in healthy and di...ls was treated with the diabetes drug Roziglitazon...tively determined in a blood plasma sample of a to...
(Date:7/2/2008)...o. In the first study of its kind, using sophistic...onally known commercial weight loss program, Weigh...s to find out which method wins in the game of goo...ined the real-life experiences of participants to ...reduce body fat and gain health benefits. The answ...
Breaking Biology News(10 mins):UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 2UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 3UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 4Study shows quantum dots can penetrate skin through minor abrasions 2Healthy or diseased? 2Weight Watchers vs. fitness centers 2VAs My HealtheVet Honored for 22Consumer Empowerment 22 8864 1VAs My HealtheVet Honored for 22Consumer Empowerment 22 8864 2Schering Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference 2396 1Schering Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference 2396 2Uninsured Benefit Once They Are Covered by Medicare 8861 1Uninsured Benefit Once They Are Covered by Medicare 8861 2Uninsured Benefit Once They Are Covered by Medicare 8861 3Uninsured Benefit Once They Are Covered by Medicare 8861 4High Blood Triglycerides Linked to Stroke Risk 8859 1High Blood Triglycerides Linked to Stroke Risk 8859 2
...ed by biologists at the University of California, ...that makes them susceptible to Bacillus thuringien...cteria and widely used by organic farmers and in g...ts. , Their findings should facilitate the design...e researchers believe also possess the molecule, f...
... to inheritance laws the scientific world has acce...o normal traits carried by their grandparents, byp...ts. , These mutant parent plants apparently have h...m the preceding generation that can be transferred... evident in the parents, according to Purdue Unive...
...ers here have used a new microscopic, three-dimens...sform themselves into fat cells, and then to funct... body. , While other studies have previously grown...e cells never completely functioned in the same wa... the genetic and biologic components that all cell...
... up to 75 percent of breast cancer,patients have a...,drugs that target different molecules along that...the disease, says a researcher from,The University...rer picture is now emerging,about the importance o... to breast cancer development, says Gordon Mills, ...
Other Biology News:UCSD discovery may help extend life of natural pesticide 2UCSD discovery may help extend life of natural pesticide 3Plants defy Mendel's inheritance laws, may prompt textbook changes 2Plants defy Mendel's inheritance laws, may prompt textbook changes 3Tiny scaffolding allows stem cells to become working fat cells 2Tiny scaffolding allows stem cells to become working fat cells 3
... Immunodepletion Kit specifically removes 20 of th...m in preparation for further proteomics analysis. ... plasma proteome whether you use one- or two-dimen... chromatography or go straight to mass spectrometr...
pLivSelect is a direct antibiotic-based selection system for recombinant identification. Recombinant selection depends solely on colony survival, eliminating the need for costly color screening. This
These stopping screens are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 screens.
...lignment, 3D structure visualization, phylogenetic...rch and more; all in a single application. Ret...ot, sort and filter them in real-time Organize yo...ing and sorting Provides up-to-date articles from...
Biology Products: